Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

338 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiac metastasis of melanoma.
Poggi R, Pantaleo MA, Benedetti G, Biasco G. Poggi R, et al. Among authors: biasco g. Melanoma Res. 2005 Aug;15(4):315-6. doi: 10.1097/00008390-200508000-00013. Melanoma Res. 2005. PMID: 16034311 No abstract available.
Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
Guida M, Riccobon A, Biasco G, Ravaioli A, Casamassima A, Freschi A, Palma MD, Galligioni E, Nortilli R, Chiarion-Sileni V, Picozzo J, Romanini A, Nanni O, Ridolfi R; Italian Melanoma Intergroup (IMI). Guida M, et al. Among authors: biasco g. Melanoma Res. 2006 Aug;16(4):317-23. doi: 10.1097/01.cmr.0000200491.00841.5f. Melanoma Res. 2006. PMID: 16845327 Clinical Trial.
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma.
Brandi G, Biasco G, Mirarchi MG, Golfieri R, Di Paolo A, Borghi A, Fanello S, Derenzini E, Agostini V, Giampalma E, Cappelli A, Pini P, Costantini S, Danesi R, Bolondi L, Piscaglia F. Brandi G, et al. Among authors: biasco g. Dig Liver Dis. 2011 Dec;43(12):1015-21. doi: 10.1016/j.dld.2011.08.005. Epub 2011 Sep 13. Dig Liver Dis. 2011. PMID: 21917536 Clinical Trial.
Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.
Brandi G, de Rosa F, Agostini V, di Girolamo S, Andreone P, Bolondi L, Serra C, Sama C, Golfieri R, Gramenzi A, Cucchetti A, Pinna AD, Trevisani F, Biasco G; Italian Liver Cancer (ITA.LI.CA) Group. Brandi G, et al. Among authors: biasco g. Oncologist. 2013;18(12):1256-7. doi: 10.1634/theoncologist.2013-0093. Epub 2013 Nov 13. Oncologist. 2013. PMID: 24232581 Free PMC article. Clinical Trial.
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study.
Berruti A, Fazio N, Ferrero A, Brizzi MP, Volante M, Nobili E, Tozzi L, Bodei L, Torta M, D'Avolio A, Priola AM, Birocco N, Amoroso V, Biasco G, Papotti M, Dogliotti L. Berruti A, et al. Among authors: biasco g. BMC Cancer. 2014 Mar 14;14:184. doi: 10.1186/1471-2407-14-184. BMC Cancer. 2014. PMID: 24628963 Free PMC article. Clinical Trial.
338 results